ARCHIVES

Jane Henney Said Tentative Choice For FDA Commissioner

This article is from The Cancer Letter archive.

Vol. 24 No. 20 | May 22, 1998

Download PDF Visit The Full Archive

Related Articles

Human Genome Project publishes its final product.

October 22, 2004

European Commission Approves Subcutaneous Rituximab

March 28, 2014

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005

Breast Removal Reduces Risk Of Cancer In BRCA Carriers

October 26, 2001